Cellular Biomedicine Group Appoints Two New Members to Scientific Advisory Board
April 30, 2015
... ... "Dr. Antonia is one of the foremost experts in the field of immuno-oncology and as a principal investigator of multiple high profile immuno-oncology clinical trials, including anti-PD-1 therapy for advanced lung cancer, has made significant strides with gene-modified tumor cell vaccine development. His research and experience in designing immunotherapy studies will no doubt advance our development of combination therapies for cancer, both in China and internationally. Professor Fan, an outstanding stem cell and neuro cell biologist, has made major contributions in the field of neuroscience and the epigenetic mechanisms underlying stem cell regulation, reprogramming, and human diseases. We look forward to Dr. Fan's research advances in the understanding of how stem cells self-renew and differentiate into specific cell types and leads to therapies for eye and neurodegenerative diseases."
I am glad to see that Peregrine KOL Scott Antonia is being sought after by other bitech companies, but I also happened to notice William S. Cohen "recommends" William Cao - CEO of Cellular Biomedicine Group and lets hope Peregrine is aware of that.
William S. Cohen may have some political pull and we just want to make sure any collaborations with Peregrine are for the best of all true long shareholders and no KOL's are bought off or even just being recruited by companies like Cellular Biomedicine Group just for info on what is the PS Targeting plan of Peregrines.
so lets see these connect the dot puzzle pieces make sense and all of a sudden McDermott finds a need for top white collar criminal lawyer Andrew E. Tomback
---------------
and not even a mention of BMS, since Innate Pharma had some dealings with BMS early on in 2011, "AFTER" sabotage at Peregrine had taken place
A Look at the Immune System When Fighting Lung Cancer Scott J. Antonia, MD, PhD David P. Carbone, MD, PhD
Drs. David Carbone and Scott Antonia explain how tumors are like humans, and they need nutrients to survive. Without those nutrients, they will die, which is why the process of angiogenesis is so important in the fight against cancer.
Published: June 3, 2015
-------------------
Is the First Treatment in Cancer the Most Critical? Scott J. Antonia, MD, PhD David P. Carbone, MD, PhD
When a patient is first diagnosed, it might seem like time is ticking, and the opportunity for treatment is so vast that an overwhelming feeling starts to surround them. But it’s important to take each day at a time.